Jaguar Health, Inc. (JAGX)
NASDAQ·Healthcare·Biotechnology
$0.25
-12.53%
Mkt Cap $1.07M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q4 2025 Nov 14, 2025 | $3.73M | $3.08M | -17.35% | -$5.08 | -$6.28 | -23.62% | — | — |
| Q3 2025 Aug 14, 2025 | $3.73M | $2.98M | -20.13% | -$5.08 | -$10.26 | -101.97% | — | — |
| Q2 2025 May 15, 2025 | $3.27M | $2.17M | -33.61% | -$18.00 | -$16.70 | +7.22% | — | — |
| Q2 2025 Apr 7, 2025 | $3.13M | $3.51M | +12.11% | -$18.50 | -$0.34 | +98.16% | — | — |
| Q4 2024 Nov 13, 2024 | $3.94M | $3.11M | -21.12% | -$2.37 | -$26.25 | -1007.59% | — | — |
| Q3 2024 Aug 13, 2024 | $3.42M | $2.72M | -20.44% | -$1.20 | -$101.00 | -8316.67% | — | — |
| Q2 2024 May 14, 2024 | $2.30M | $2.35M | +2.22% | -$38.73 | -$90.36 | -133.33% | — | — |
| Q2 2024 Apr 1, 2024 | $2.61M | $2.30M | -11.88% | -$1470.00 | -$594.64 | +59.55% | — | — |
| Q4 2023 Nov 14, 2023 | $2.61M | $2.81M | +7.78% | -$1.23 | -$572.29 | -46427.64% | — | — |
| Q3 2023 Aug 14, 2023 | $3.26M | $2.68M | -17.91% | -$1.53 | -$632.53 | -41241.83% | — | — |
| Q2 2023 May 15, 2023 | $3.26M | $1.97M | -39.51% | -$6750.00 | -$3599.40 | +46.68% | — | — |
| Q2 2023 Apr 28, 2023 | — | $3.26M | — | — | -$631129.00 | — | — | — |
| Q4 2022 Nov 14, 2022 | $3.55M | $3.15M | -11.27% | -$5.62 | -$13588.20 | -241682.92% | — | — |
| Q3 2022 Aug 22, 2022 | $3.10M | $2.92M | -5.77% | -$16.50 | -$13588.20 | -82252.73% | — | — |
| Q2 2022 May 10, 2022 | $1.60M | $2.63M | +64.06% | -$12.75 | -$45294.00 | -355147.06% | — | — |
| Q1 2022 Mar 11, 2022 | $8.40M | $2.08M | -75.24% | -$6.75 | -$35102.80 | -519941.48% | — | — |
| Q4 2021 Nov 17, 2021 | $2.77M | $630.00K | -77.26% | -$12.75 | -$30573.40 | -239691.37% | — | — |
| Q3 2021 Aug 13, 2021 | $385.00K | $385.00K | +0.00% | -$3.00 | -$33973.90 | -1132363.33% | — | — |
| Q2 2021 May 17, 2021 | $3.35M | $1.24M | -62.96% | -$1.50 | -$33973.90 | -2264826.67% | — | — |
| Q1 2021 Mar 31, 2021 | — | $2.58M | — | -$22.50 | -$33.75 | -50.00% | — | — |